SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001437749-26-001111 from cbdMD, Inc. (YCBD)

cbdMD, Inc.
Date: Jan. 12, 2026 · CIK: 0001644903 · Accession: 0001437749-26-001111

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-292567

Date
January 12, 2026
Author
/s/ T. Ronan Kennedy
Form
CORRESP
Company
cbdMD, Inc.

Letter

ycbd20260112_corresp.htm

cbdMD, Inc.

2101 Westinghouse Blvd., Suite A

Charlotte, NC 28273

January 12, 2026

Via EDGAR

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, N.E.

Washington, D. C. 20549

Re:

cbdMD, Inc.

Registration Statement on Form S-1

File No. 333-292567

Ladies and Gentlemen:

In accordance with Rule 461 promulgated pursuant to the Securities Act of 1933, cbdMD, Inc. is hereby requesting that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30 p.m. EST on January 13, 2026, or as soon thereafter as is practicable.

If you have any questions regarding this request, please contact either Brian Pearlman or Brian Bernstein, our legal counsel, at (954) 880-9484.

Very truly yours,
/s/ T. Ronan Kennedy

Show Raw Text
CORRESP
 1
 filename1.htm

 ycbd20260112_corresp.htm

 cbdMD, Inc.

 2101 Westinghouse Blvd., Suite A

 Charlotte, NC 28273

 January 12, 2026

 Via EDGAR

 Division of Corporation Finance

 Securities and Exchange Commission

 100 F Street, N.E.

 Washington, D. C. 20549

 Re:

 cbdMD, Inc.

 Registration Statement on Form S-1

 File No. 333-292567

 Ladies and Gentlemen:

 In accordance with Rule 461 promulgated pursuant to the Securities Act of 1933, cbdMD, Inc. is hereby requesting that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30 p.m. EST on January 13, 2026, or as soon thereafter as is practicable.

 If you have any questions regarding this request, please contact either Brian Pearlman or Brian Bernstein, our legal counsel, at (954) 880-9484.

 Very truly yours,

 /s/ T. Ronan Kennedy

 T. Ronan Kennedy

 Chief Executive Officer and Chief Financial Officer

 cc:

 Brian A. Pearlman, Esq.

 Brian S. Bernstein, Esq.